← Back to Clinical Trials
Recruiting NCT07297823

NCT07297823 Sex Differences in Cold-Induced Changes in Maximal Fat Oxidation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07297823
Status Recruiting
Phase
Sponsor Colorado State University
Condition Exercise
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-04-15
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Cold temperatureRoom Temperature

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-04-15 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research study is to determine if the cold-induced change in fat burning during exercise is different between females and males.

Eligibility Criteria

Inclusion Criteria: * Age 18-40 years (inclusive) * Weight stable (no change in body mass greater than 5 lbs. within the previous 6 months. * Willing to abstain from caffeine and alcohol for 24-hours prior to two different study visits * Competency in English as informally assessed by comprehension of the Informed Consent. This study involves maximal exercise testing; for safety reasons, the ability for clear and rapid communication will be necessary between the research participants and the investigators. * Regular exercise (i.e., at least 150 minutes of moderate-vigorous exercise per week) Exclusion Criteria: * Use of hormonal contraceptives * History of autonomic, cardio-pulmonary, and/or metabolic disease (including heart failure, hypertension, arrhythmia, vascular disease, and/or diabetes) * Pregnancy or breast feeding * Habitual use of tobacco/nicotine products or recreational drugs (2 or more uses within the previous month)

Contact & Investigator

Central Contact

Christopher Bell

✉ Christopher.Bell@colostate.edu

📞 9704917522

Principal Investigator

Christopher Bell

PRINCIPAL INVESTIGATOR

Colorado State University

Frequently Asked Questions

Who can join the NCT07297823 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Exercise. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07297823 currently recruiting?

Yes, NCT07297823 is actively recruiting participants. Contact the research team at Christopher.Bell@colostate.edu for enrollment information.

Where is the NCT07297823 trial being conducted?

This trial is being conducted at Fort Collins, United States.

Who is sponsoring the NCT07297823 clinical trial?

NCT07297823 is sponsored by Colorado State University. The principal investigator is Christopher Bell at Colorado State University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology